Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christian Giedl"'
Autor:
Sanzhar Shalekenov, Atiqullah Aziz, Arndt Hartmann, Julius Schäfer, Johannes Breyer, Eva Maria Lausenmeyer, Christian Giedl, Stefan Denzinger, Bastiaan W.G. van Rhijn, Matthias Evert, Johannes Bründl, Maximilian Burger, Wolfgang Otto
Publikováno v:
Bladder Cancer (Amsterdam, Netherlands)
Objectives: To investigate the predictive impact of the proliferation biomarker Ki-67 on the clinical course of patients with initial stage pTa urothelial carcinoma of the bladder (UCB). Methods: We retrospectively analyzed all patients treated by tr
Autor:
Stella Koufou, Jens-Claudio Lunz, Arndt Hartmann, Anja Rogler, Albert Borchardt, Wolf F. Wieland, Tilman T. Rau, Nadine T. Gaisa, Christian Giedl, Bastian Keck, Burkhard Kneitz, Robert Stoehr, Christian Hafner
Publikováno v:
Pathobiology. 77:249-252
Objective: The mutational constitutive activation of FGFR3 has been discovered in several malignancies but only limited data on FGFR3 mutations in prostate cancer are available. Most recently, activating FGFR3 mutations were described as being associ
Autor:
Michael Gierth, Wolfgang Otto, Atiqullah Aziz, Stefan Denzinger, Sanzhar Shalekenov, Ferdinand Hofstädter, Maximilian Burger, Julius Schäfer, Christian Giedl, Johannes Breyer
Publikováno v:
World journal of urology. 34(5)
To determine whether the immunohistochemical markers survivin and E-cadherin can predict progress at initially diagnosed Ta bladder cancer. We retrospectively searched for every initially diagnosed pTa urothelial bladder carcinoma having been treated
Autor:
Ferdinand Hofstädter, Peter Rubenwolf, Stefan Denzinger, Maximilian Burger, Johannes Breyer, Hans-Martin Fritsche, Wolf F. Wieland, Johannes Bründl, W. Rößler, Christian Giedl, Michael Gierth, Atiqullah Aziz, Wolfgang Otto
Publikováno v:
Urologia internationalis. 93(3)
Objective: Outcome prediction of pT3 urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC) remains challenging. The objective of our study was to determine high-risk patients with poor survival outcome in a heterogeneous group subst
Autor:
Ferdinand Hofstädter, Marcus Bettstetter, Tina Bocker Edmonston, Matthias Woenckhaus, Christian Giedl, Benedikt Gröschl, Wolfgang Dietmaier
Publikováno v:
International journal of cancer. 132(7)
DUSP4 (MKP-2), a member of the mitogen-activated protein kinase phosphatase (MKP) family and potential tumor suppressor, negatively regulates the MAPKs (mitogen-activated protein kinases) ERK, p38 and JNK. MAPKs play a crucial role in cancer developm
Autor:
Stella, Koufou, Jens-Claudio, Lunz, Albert, Borchardt, Bastian, Keck, Burkhard, Kneitz, Nadine T, Gaisa, Christian, Hafner, Christian, Giedl, Tilman T, Rau, Anja, Rogler, Wolf F, Wieland, Arndt, Hartmann, Robert, Stoehr
Publikováno v:
Pathobiology : journal of immunopathology, molecular and cellular biology. 77(5)
The mutational constitutive activation of FGFR3 has been discovered in several malignancies but only limited data on FGFR3 mutations in prostate cancer are available. Most recently, activating FGFR3 mutations were described as being associated with l